Hjem › Indolent multipelt myelom
Indolent multipelt myelom kliniske forsøg rekrutterer i USA
20 studier for Indolent multipelt myelom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Boston, MA6 studier
- New York City, NY6 studier
- Atlanta, GA5 studier
- Denver, CO3 studier
- Durham, NC3 studier
- Houston, TX3 studier
- Columbus, OH3 studier
- Salt Lake City, UT3 studier
- Edison, NJ3 studier
Efter delstat
- Colorado3 studier
- Florida4 studier
- Georgia5 studier
- Massachusetts6 studier
- Michigan4 studier
- New Jersey3 studier
- New York8 studier
- North Carolina4 studier
- Ohio3 studier
- Texas4 studier
- Utah3 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06768489A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07393282Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT03937635Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 16. jul. 2026 · NCT05469893CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 30 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT06644625A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 8. jul. 2026 · NCT06140524Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. jun. 2026 · NCT04776395Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 7. maj 2026 · NCT02269592FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. maj 2026 · NCT07446777Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 21. apr. 2026 · NCT02726750A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT05640843Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 15. apr. 2026 · NCT05136807Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 9. apr. 2026 · NCT05361694Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 17. feb. 2026 · NCT06212323Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. dec. 2025 · NCT05312255Registry for Adults With Plasma Cell Disorders (PCD's)
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 20. nov. 2025 · NCT03717844A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 13. nov. 2025 · NCT06055894The Indiana Myeloma Registry
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 10. nov. 2025 · NCT03616483Screening for AL Amyloidosis in Smoldering Multiple Myeloma
RekruttererObservationsstudie
Alder 40 og opefter · Alle køn · Opdateret 6. aug. 2025 · NCT06365060Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 10. feb. 2025 · NCT05597345Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.